Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy-Reference-Cited by-同舟云学术

Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy

Published:2024-05-17 Issue:7 Volume:76 Page:628-637
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Lin Chien-Yu¹²,Huang Pei-Wei³,Hsieh Chia-Hsun²³,Hsu Cheng-Lung²³,Liau Chi-Ting³,Huang Shiang-Fu²⁴,Liao Chun-Ta²⁴,Chang Tung-Chieh¹²,Wang Hung-Ming²³

Affiliation:

1. Department of Radiation Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

2. College of Medicine, Chang Gung University, Taoyuan, Taiwan

3. Division of Medical Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

4. Section of Head and Neck Surgery, Department of Otorhinolaryngology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

Funder

Chang Gung Medical Foundation IRB

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2024.2352185

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

3. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group

4. Critical weight loss in head and neck cancer—prevalence and risk factors at diagnosis: an explorative study

5. Cancer cachexia update in head and neck cancer: Definitions and diagnostic features